Health News (Reuters)

Meat tracking key to fight African swine fever: OIE

Tracking meat and meat products from pigs infected with African swine fever is key to fight the spread of the highly viral disease as it can survive in processed food, the Deputy head of the World Organisation for Animal Health (OIE) said on Monday.

Vaping residue can transfer between rooms

(Reuters Health) - Nicotine and other chemicals exhaled by e-cigarette smokers can move through air vents, leaving residue on surfaces in other locations, a new study found.

Merck's Keytruda clocks up new win as EU approves chemo cocktail

Merck & Co's key cancer drug Keytruda has been approved for use in Europe in combination with chemotherapy in previously untreated lung cancer patients, marking a further advance for the product after uncertainty about its EU prospects a year ago.

Roche faces UK pricing row over multiple sclerosis drug Ocrevus

Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).

South Korean man infected by MERS virus, first case in 3 years

A South Korean man, 61, was diagnosed with the potentially deadly Middle East Respiratory Syndrome (MERS) and is being treated at a hospital in Seoul, the Korea Centers for Disease Control and Prevention (KCDC) said on Saturday.

Youth soccer injury prevention program saves healthcare costs

(Reuters Health) - An injury prevention program tailored to children's soccer is not only more effective than typical warmups and stretches at keeping players safe, it's also associated with lower healthcare costs, a Swiss study suggests.

HIV prevention pill reaching more people who need it

(Reuters Health) - More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.

J&J to work with India on compensation for recalled hip implants

Johnson & Johnson (J&J) said it would work with the Indian government to compensate patients who had suffered from hip implants that were recalled by the U.S. healthcare firm eight years ago after data showed high failure rates.

Pages